Homotypic cell membrane-camouflaged biomimetic PLGA nanoparticle loading triptolide for the treatment of hepatocellular carcinoma

References

• Chen Z, Zhao P, Luo Z, et al. (2016). Cancer cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy. ACS Nano 10:10049–57. doi: 10.1021/acsnano.6b04695.
   PubMed Web of Science ®Google Scholar
• Fang RH, Gao W, Zhang L. (2023). Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol 20:33–48. doi: 10.1038/s41571-022-00699-x.
   PubMed Web of Science ®Google Scholar
• Fang RH, Kroll AV, Gao W, et al. (2018). Cell membrane coating nanotechnology. Adv Mater 30:e1706759.
   PubMed Web of Science ®Google Scholar
• Feng J, Dai W, Mao Y, et al. (2020). Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1alpha/PPAR-gamma/PKM2-mediated glycolysis. J Exp Clin Cancer Res 39:24. doi: 10.1186/s13046-020-1528-x.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. (2018). Hepatocellular carcinoma. Lancet 391:1301–14.
   PubMed Web of Science ®Google Scholar
• Ganesan P, Kulik LM. (2023). Hepatocellular carcinoma: new developments. Clin Liver Dis 27:85–102. doi: 10.1016/j.cld.2022.08.004.
   PubMed Web of Science ®Google Scholar
• Jin J, Krishnamachary B, Barnett JD, et al. (2019). Human cancer cell membrane-coated biomimetic nanoparticles reduce fibroblast-mediated invasion and metastasis and induce T-cells. ACS Appl Mater Interfaces 11:7850–61.
   PubMed Web of Science ®Google Scholar
• Lara-Cruz C, Jimenez-Salazar JE, Arteaga M, et al. (2019). Gold nanoparticle uptake is enhanced by estradiol in MCF-7 breast cancer cells. Int J Nanomedicine 14:2705–18.
   PubMed Web of Science ®Google Scholar
• Liang C, Dong Z, Cai X, et al. (2020). Hypoxia induces sorafenib resistance mediated by autophagy via activating FOXO3a in hepatocellular carcinoma. Cell Death Dis 11:1017. doi: 10.1038/s41419-020-03233-y.
   PubMed Web of Science ®Google Scholar
• Ling D, Xia H, Park W, et al. (2014). pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma. ACS Nano 8:8027–39. doi: 10.1021/nn502074x.
   PubMed Web of Science ®Google Scholar
• Liu M, Song W, Du X, et al. (2018). NQO1-selective activated prodrug of triptolide: synthesis and antihepatocellular carcinoma activity evaluation. ACS Med Chem Lett 9:1253–7.
   PubMed Web of Science ®Google Scholar
• Operti MC, Bernhardt A, Grimm S, et al. (2021). PLGA-based nanomedicines manufacturing: technologies overview and challenges in industrial scale-up. Int J Pharm 605:120807. doi: 10.1016/j.ijpharm.2021.120807.
   PubMed Web of Science ®Google Scholar
• Soprano E, Polo E, Pelaz B, et al. (2022). Biomimetic cell-derived nanocarriers in cancer research. J Nanobiotechnol 20:538. doi: 10.1186/s12951-022-01748-4.
   PubMed Web of Science ®Google Scholar
• Su J, Liu G, Lian Y, et al. (2018). Preparation and characterization of erythrocyte membrane cloaked PLGA/arsenic trioxide nanoparticles and evaluation of their in vitro anti-tumor effect. RSC Adv 8:20068–76.
   PubMed Web of Science ®Google Scholar
• Sun YY, Xiao L, Wang D, et al. (2017). Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53. Int J Oncol 50:847–52. doi: 10.3892/ijo.2017.3850.
   PubMed Web of Science ®Google Scholar
• Wang H, Wu J, Williams GR, et al. (2019). Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery. J Nanobiotechnol 17:60. doi: 10.1186/s12951-019-0494-y.
   PubMed Web of Science ®Google Scholar
• Wang S, Jiang H, Wang J, et al. (2021). Superior in vitro anticancer effect of biomimetic paclitaxel and triptolide co-delivery system in gastric cancer. J Biomed Res 35:327–38. doi: 10.7555/JBR.35.20210102.
   PubMed Web of Science ®Google Scholar
• Wu X, Li Y, Raza F, et al. (2021). Red blood cell membrane-camouflaged tedizolid phosphate-loaded PLGA nanoparticles for bacterial-infection therapy. Pharmaceutics 13:99. doi: 10.3390/pharmaceutics13010099.
   PubMed Web of Science ®Google Scholar
• Xiong J, Wu M, Chen J, et al. (2021). Cancer-erythrocyte hybrid membrane-camouflaged magnetic nanoparticles with enhanced photothermal-immunotherapy for ovarian cancer. ACS Nano 15:19756–70. doi: 10.1021/acsnano.1c07180.
   PubMed Web of Science ®Google Scholar
• Yalikong A, Li XQ, Zhou PH, et al. (2021). A triptolide loaded HER2-targeted nano-drug delivery system significantly suppressed the proliferation of HER2-positive and BRAF mutant colon cancer. Int J Nanomedicine 16:2323–35.
   PubMed Web of Science ®Google Scholar
• Yu L, Wang Z, Mo Z, et al. (2021). Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy. Acta Pharm Sin B 11:2004–15.
   PubMed Web of Science ®Google Scholar
• Yuan H, Xia P, Sun X, et al. (2022). Photothermal nanozymatic nanoparticles induce ferroptosis and apoptosis through tumor microenvironment manipulation for cancer therapy. Small 18:e2202161. doi: 10.1002/smll.202202161.
   PubMed Web of Science ®Google Scholar
• Zhang Y, He Z, Li Y, et al. (2021). Tumor cell membrane-derived nano-Trojan horses encapsulating phototherapy and chemotherapy are accepted by homologous tumor cells. Mater Sci Eng C Mater Biol Appl 120:111670.
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu X, Zhang P, et al. (2019). Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma. Acta Pharm Sin B 9:1050–60.
   PubMed Web of Science ®Google Scholar
• Zheng W, Wang C, Ding R, et al. (2019). Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity. Int J Pharm 572:118721. doi: 10.1016/j.ijpharm.2019.118721.
   PubMedGoogle Scholar
• Zheng Y, Kong F, Liu S, et al. (2021). Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy. Drug Deliv 28:2033–43.
   PubMed Web of Science ®Google Scholar
• Zhu D, Zhang Q, Chen Y, et al. (2022). Mechanochemical preparation of triptolide-loaded self-micelle solid dispersion with enhanced oral bioavailability and improved anti-tumor activity. Drug Deliv 29:1398–408.
   PubMed Web of Science ®Google Scholar
• Zhu L, Kalimuthu S, Gangadaran P, et al. (2017). Exosomes derived from natural killer cells exert therapeutic effect in melanoma. Theranostics 7:2732–45. doi: 10.7150/thno.18752.
   PubMed Web of Science ®Google Scholar